Results of Meetings
Summary by AI BETAClose X
Thursday, 20 November 2025
KR1 plc (the "Company")
Results of Annual and Extraordinary General Meetings
KR1 plc (KR1:AQSE), a leading digital asset company, is pleased to announce that all Resolutions were duly passed at the Annual General Meeting and the Extraordinary General Meeting of the Company held earlier today.
The votes cast at the meetings are set out in the tables below.
Annual General Meeting
|
Resolution |
For |
Against |
Total votes cast as % of Issued Share Capital |
Votes Withheld |
||
|
Number of Votes |
% of shares voted |
Number of Votes |
% of shares voted |
|||
|
1. To receive the 2024 report & accounts. |
53,598,207
|
99.8% |
90,392 |
0.2% |
30.2% |
174,225 |
|
2. To re-appoint PKF Littlejohn LLP as auditors. |
53,577,269
|
98.3% |
94,392 |
1.7% |
30.7% |
191,163 |
|
3. To re-elect Rhys Davies as a director. |
50,817,145
|
94.7% |
2,841,555 |
5.3% |
30.2% |
204,124 |
|
4. To re-elect Aeron Buchanan as a director. |
53,466,139
|
99.6% |
192,561 |
0.4% |
30.2% |
204,124 |
|
5. To re-elect Mona Elisa as a director. |
53,165,051
|
99.1% |
493,649 |
0.9% |
30.2% |
204,124 |
|
6. To re-elect George McDonaugh as a director. |
52,081,570
|
97.0% |
1,589,130 |
3.0% |
30.2% |
192,124 |
|
7. To re-elect Keld van Schreven as a director. |
52,081,570
|
97.0% |
1,589,130 |
3.0% |
30.2% |
192,124 |
Extraordinary General Meeting
|
Resolution |
For |
Against |
Total votes cast as % of Issued Share Capital |
Votes Withheld |
||
|
Number of Votes |
% of shares voted |
Number of Votes |
% of shares voted |
|||
|
1. To adopt the New Articles.
|
52,305,428
|
99.7% |
165,247 |
0.3% |
29.5% |
155,079 |
|
2. To authorise the allotment of ordinary shares in connection with the Placing Programme |
51,770,426
|
98.7% |
666,587 |
1.3% |
29.5% |
188,741
|
|
3. To authorise the allotment of ordinary shares in connection with any Performance Fees. |
51,798,212
|
98.8% |
636,547 |
1.2% |
29.5% |
190,995 |
|
4. To authorise the Company to make market acquisitions of ordinary shares. |
52,304,435
|
99.7% |
164,600 |
0.3% |
29.5% |
156,719 |
The 'for' votes include those giving discretion to the Chairman. A 'vote withheld' is not a vote in law and is not counted in the calculation of the votes 'for' or 'against' a resolution.
In accordance with the Company's announcement of 29 October 2025, application has been made to the FCA and the London Stock Exchange for the Company's ordinary shares to be admitted to the equity shares (commercial companies) category of the Official List and to trading on the Main Market of the London Stock Exchange. It is expected that admission will become effective and that dealings in the Company's ordinary shares will commence at 8.00 a.m. on 25 November 2025.
Accordingly, admission of the Company's ordinary shares to trading on the Apex segment of the Aquis Growth Market will be cancelled, with the last day of trading expected to be 24 November 2025.
For further information please contact:
KR1 plc
George McDonaugh, Keld van Schreven
Phone: +44 (0)1624 630 630
Email: investors@KR1.io
AlbR Capital Limited (Aquis Corporate Adviser)
Phone: +44 (0)20 7469 0930
Email: info@albrcapital.com
Singer Capital Markets (Sponsor, Financial Adviser and Broker)
Investment Banking: Alex Bond, James Maxwell, James Fischer, Oliver Platts
Equity Sales: William Gumpel, James Waterlow
Phone: +44 (0)20 7496 3000
Email: enquiries@singercm.com
SEC Newgate (Financial Communications)
Bob Huxford, Ian Silvera, Dafydd Rees
Phone: +44(0)20 3757 6882
Email: KR1@secnewsgate.co.uk
About KR1 plc
KR1 plc is a leading digital asset company focused on decentralised technologies and the generation of income from digital assets, primarily through staking activities on proof-of-stake networks. Through the Company's staking activities, KR1 plc helps to secure networks by supporting transaction validation, maintaining network integrity and contributing to decentralisation and, in return, receives staking rewards. www.KR1.io
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 2 hours ago Luceco
- 2 hours ago Helios Towers
- 3 hours ago Wise Class A
- 3 hours ago EDX Medical Group Plc
- 3 hours ago Naked Wines